(Q39499164)

English

Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years. The North American Finasteride Study Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years. The North American Finasteride Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

prostatic hypertrophy

1 reference

based on heuristic

inferred from title

author name string

Hudson PB

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Boake R

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Trachtenberg J

3

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Romas NA

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Rosenblatt S

5

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Narayan P

6

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Geller J

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Lieber MM

8

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Elhilali M

9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Norman R

10

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Patterson L

11

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Perreault JP

12

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Malek GH

13

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Bruskewitz RC

14

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Roy JB

15

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Ko A

16

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Jacobsen CA

17

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Stoner E

18

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

0 references

publication date

1 April 1999

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

690-695

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of a symptoms questionnaire for benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Can finasteride reverse the progress of benign prostatic hyperplasia? A two-year placebo-controlled study. The Scandinavian BPH Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia. Terazosin Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of prostatism: urinary flow rates in a community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900666-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0090-4295(98)00666-9

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39499164&oldid=1832143236"